Sign In
Buy JAZZ
$230.93
+4.81 (+2.13%)
At Close: Jun 03, 2026
Twenty-one abstracts, including 11 late-breaking abstracts, underscore Jazz's unwavering commitment to advancing the treatment of narcolepsy and idiopathic hypersomnia For U.S. media and investors onl
Jazz Pharmaceuticals plc (JAZZ) Presents at Jefferies Global Healthcare Conference 2026 Transcript
02:12pm, Wednesday, 03'rd Jun 2026
Jazz Pharmaceuticals plc (JAZZ) Presents at Jefferies Global Healthcare Conference 2026 Transcript
Here's Why Jazz Pharmaceuticals (JAZZ) is a Strong Momentum Stock
10:51am, Monday, 01'st Jun 2026
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Expanded safety, subgroup, progression-free survival sensitivity and subsequent therapy analyses further characterize the consistency and durability of outcomes observed with zanidatamab-containing co
Jazz Pharmaceuticals plc (JAZZ) Presents at TD Cowen's 7th Annual Oncology Innovation Summit: Insights for ASCO & EHA Transcript
04:27pm, Wednesday, 27'th May 2026
Jazz Pharmaceuticals plc (JAZZ) Presents at TD Cowen's 7th Annual Oncology Innovation Summit: Insights for ASCO & EHA Transcript
Here's Why Jazz Pharmaceuticals (JAZZ) is a Strong Value Stock
10:40am, Tuesday, 26'th May 2026
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
UBS Just Upgraded Jazz Pharma to Buy. New $307 Price Target Could Signal a Turning Point
12:24pm, Tuesday, 19'th May 2026
One of Wall Street's major firms just put its stamp of approval on a specialty pharma name that has been quietly rallying.
Jazz Pharmaceuticals plc (JAZZ) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript
10:51am, Tuesday, 19'th May 2026
Jazz Pharmaceuticals plc (JAZZ) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript
Pre-Market Stock Futures: Futures are trading lower on Tuesday as the sell-off in technology stocks carried through to Monday and is headed down that road today. All of the major indices, except the D
Does Epidiolex Make Jazz Pharmaceuticals a Unique Cannabis Stock?
09:00am, Wednesday, 13'th May 2026
JAZZ gains unique cannabis exposure through Epidiolex as strong sales growth and patent protection boost long-term visibility.
Jazz Pharmaceuticals to Participate in Upcoming Investor Conferences
04:15pm, Tuesday, 12'th May 2026
DUBLIN, May 12, 2026 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that company management will participate in fireside chats at the following investor conferences: 2026 RBC
Here's Why Jazz Pharmaceuticals (JAZZ) is a Strong Momentum Stock
10:51am, Tuesday, 12'th May 2026
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
International Markets and Jazz (JAZZ): A Deep Dive for Investors
10:16am, Monday, 11'th May 2026
Examine the evolution of Jazz's (JAZZ) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects.
Here's Why Jazz Pharmaceuticals (JAZZ) is a Strong Value Stock
10:40am, Friday, 08'th May 2026
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Jazz Pharmaceuticals Q1 Review: The Oncology Pivot Is Real, And The Market Is Still Mispricing It
04:21pm, Wednesday, 06'th May 2026
Jazz Pharmaceuticals remains a Strong Buy, with Q1 2026 results affirming robust growth and a successful pivot into oncology. JAZZ's oncology segment, led by Ziihera, Modeyso, and Zepzelca, is driving
